Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | HRH1 | P35367 | 1/20 | 0.33 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA3 | P07451 | 1/20 | 0.30 |
| ▸ | CA4 | P22748 | 1/20 | 0.30 |
| ▸ | CA6 | P23280 | 1/20 | 0.30 |
| ▸ | CA5A | P35218 | 1/20 | 0.30 |
| ▸ | CA7 | P43166 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.30 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL823290 | 0.85 | ALDH1A1 (0.39) | THRBLMNAHTR2AHRH1DNM1 | |
| SCHEMBL24246368 | 0.83 | — | — | |
| SCHEMBL11379275 | 0.77 | THRB (0.35) | THRBLMNAALDH1A1SMN1; SMN2 | |
| SCHEMBL5666168 | 0.76 | THRB (0.50) | THRBLMNA | |
| SCHEMBL28411291 | 0.75 | THRB (0.33) | THRBLMNAHTR2AHRH1 | |
| SCHEMBL1254070 | 0.73 | DNM1 (0.48) | THRBDNM1CA12CA2CA3 | |
| SCHEMBL5545778 | 0.73 | — | — | |
| SCHEMBL20548483 | 0.73 | THRB (0.32) | THRBLMNA | |
| SCHEMBL24484446 | 0.73 | LMNA (0.42) | THRBLMNAHTR2AHRH1 | |
| Hydrochloric Acid SCHEMBL11179561 | 0.73 | THRB (0.32) | THRBLMNAHTR2AHRH1DNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4280927-A | A CHELATE OF HYDROCARBYL LITHIUM AND A DIALKYLAMINOALDEHYDE DIALKYL ACETAL | THE FIRESTONE TIRE & RUBBER COMPANY (US) | 1981-07-28 | — | — | US | claimed |
| WO-2025235840-A1 | ECHINOCANDIN-LIKE AND BORON-CONTAINING ECHINOCANDIN COMPOUNDS AND THEIR USE AS AGROCHEMICAL FUNGICIDES | 5METIS, INC. (US) | 2025-11-13 | — | — | WO | disclosed |
| EP-4644377-A1 | LIPID COMPOUND FOR GENE DELIVERY AND LIPID NANOPARTICLE COMPRISING SAME | NANJING CYBERNAX BIOMEDICAL TECHNOLOGY CO., LTD. (CN) | 2025-11-05 | — | — | EP | disclosed |
| CN-119219823-A | Adsorbent with heparin slow release function, preparation method thereof and blood perfusion device | 泉州师范学院 | 2024-12-31 | — | — | CN | disclosed |
| CN-110072865-B | Pyrrolo-aromatic heterocyclic compounds, preparation method and medical application thereof | 中国医药研究开发中心有限公司 | 2022-02-11 | — | — | CN | disclosed |
| CN-113121512-A | Preparation method of quinazolinyl butene amide compound | 江苏晶立信医药科技有限公司 | 2021-07-16 | — | — | CN | disclosed |
| EP-1489078-B1 | BENZOFURAN DERIVATIVE | MITSUBISHI TANABE PHARMA CORP (JP) | 2010-01-06 | — | — | EP | disclosed |
| US-20090209511-A1 | Benzofuran Derivatives | KAWAGUCHI TAKAYUKI | 2009-08-20 | — | — | US | disclosed |
| US-7531537-B2 | Benzofuran derivative | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2009-05-12 | — | — | US | disclosed |
| CN-100439351-C | Benzofuran derivative | TANABE SEIYAKU CO (JP) | 2008-12-03 | — | — | CN | disclosed |
| US-20050282808-A1 | Benzofuran derivative | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2005-12-22 | — | — | US | disclosed |
| CN-1656086-A | Benzofuran derivative | TANABE SEIYAKU CO (JP) | 2005-08-17 | — | — | CN | disclosed |
| EP-1489078-A1 | BENZOFURAN DERIVATIVE | Tanabe Seiyaku Co., Ltd. (JP) | 2004-12-22 | — | — | EP | disclosed |
| US-4329439-A | AN ORGANOLITHIUM COMPONENT, AND AN AMINO-ACETAL COMPONENT OF THE CATALYST | THE FIRESTONE TIRE & RUBBER COMPANY (US) | 1982-05-11 | — | — | US | disclosed |
| US-4280927-A | A CHELATE OF HYDROCARBYL LITHIUM AND A DIALKYLAMINOALDEHYDE DIALKYL ACETAL | THE FIRESTONE TIRE & RUBBER COMPANY (US) | 1981-07-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050282808-A1 | Benzofuran derivative | F12, F2, F11 | THRB 3799/4885LMNA 3104/4885HTR2A 3664/4885 |
| US-20090209511-A1 | Benzofuran Derivatives | F12, F2, F3 | THRB 3790/4885LMNA 2928/4885HTR2A 3567/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.